Hiv-1 Infection Market Share, Key Trends, Regional Outlook & Forecasts to 2016

HIV-1 Infection market, Key Trends, Application Analysis, Regional Outlook & Forecasts to 2016

Global Markets Direct's, 'HIV-1 Infection - Pipeline Review, H2 2015', provides an overview of the HIV-1 Infection's therapeutic pipeline.

This report provides comprehensive information on the therapeutic development for HIV-1 Infection, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for HIV-1 Infection and special features on late-stage and discontinued projects.

Browse Detail Report With TOC @

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information.

Table Of Content

Table Of Contents 2
Introduction 6

Buy a Sample copy of This Report @

HIV-1 Infection Overview 7
Therapeutics Development 8
HIV-1 Infection - Therapeutics under Development by Companies 10
HIV-1 Infection - Therapeutics under Investigation by Universities/Institutes 15
HIV-1 Infection - Pipeline Products Glance 19
HIV-1 Infection - Products under Development by Companies 22
HIV-1 Infection - Products under...